Evidence map›Paper›PMID 30406213›Full record

ArticleAntibody therapeutics2018

Selectivity Conversion of Protease Inhibitory Antibodies.

Tyler Lopez, Aaron Ramirez, Chris Benitez, Zahid Mustafa, Henry Pham, Ramon Sanchez, Xin Ge

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibody therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tyler LopezDepartment of Chemical and Environmental Engineering, Bourns College of Engineering, University of California Riverside, Riverside, CA, USA.
Aaron RamirezDepartment of Chemical and Environmental Engineering, Bourns College of Engineering, University of California Riverside, Riverside, CA, USA.
Chris BenitezDepartment of Chemical and Environmental Engineering, Bourns College of Engineering, University of California Riverside, Riverside, CA, USA.
Zahid MustafaDepartment of Chemical and Environmental Engineering, Bourns College of Engineering, University of California Riverside, Riverside, CA, USA.
Henry PhamDepartment of Chemical and Environmental Engineering, Bourns College of Engineering, University of California Riverside, Riverside, CA, USA.
Ramon SanchezDepartment of Chemical and Environmental Engineering, Bourns College of Engineering, University of California Riverside, Riverside, CA, USA.
Xin GeDepartment of Chemical and Environmental Engineering, Bourns College of Engineering, University of California Riverside, Riverside, CA, USA.
University of California, Riverside · US

Funding

Structure-based design of camel-like human selective mAbs against MMPs in diseaseR01GM115672 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI GE, XIN · 2016 to 2020
$1.5M
NIGMS NIH HHS R01 GM115672
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FACSinhibitory antibodyMMPproteaseselectivity

Identifiers

PMID30406213
PMCPMC6206439
OpenAlexW2894626754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.